Published in Mol Med Rep on October 08, 2012
A New View of Vitiligo: Looking at Normal-Appearing Skin. J Invest Dermatol (2015) 0.79
Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes. J Invest Dermatol (2013) 0.78
The role of IL-17 in vitiligo: A review. Autoimmun Rev (2016) 0.76
Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency. PLoS One (2013) 0.76
Evaluation of dry eye findings in patients with vitiligo. Pak J Med Sci (2015) 0.75
Role of in vivo reflectance confocal microscopy in determining stability in vitiligo: a preliminary study. Indian J Dermatol (2013) 0.75
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med (2000) 3.32
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev (2011) 2.42
The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med (2009) 2.38
The effects of IL-6 on CD4 T cell responses. Clin Immunol (2008) 1.90
Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res (2003) 1.90
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A (2003) 1.80
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol (2009) 1.56
New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res (2002) 1.42
Properties and origin of human Th17 cells. Mol Immunol (2009) 1.42
Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest (2003) 1.41
Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest (2000) 1.39
Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunol Rev (2004) 1.37
The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol (2010) 1.35
Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun (2008) 1.31
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol (2001) 1.21
Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol (2002) 1.21
An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol (1993) 1.21
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest (2002) 1.15
Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond) (2011) 1.14
Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo. J Invest Dermatol (1997) 1.04
Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res (2012) 0.98
Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells. J Immunol (1998) 0.94
Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin? Pigment Cell Res (2003) 0.93
Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci (2003) 0.90
Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults. J Eur Acad Dermatol Venereol (2011) 0.86
Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells. Cancer Immunol Immunother (2007) 0.85
Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation. Br J Dermatol (2011) 0.84
Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo. Br J Dermatol (2000) 0.84
IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis. Rheumatol Int (2010) 0.84
Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. Arch Dermatol (2002) 0.83
Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells. Eur J Pharmacol (2010) 0.81
Sample size determination in clinical trials with an emphasis on exponentially distributed responses. Biometrics (1987) 0.78
Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res (1995) 0.77
Cutaneous metastatic angiosarcoma with a lethal outcome, following radiotherapy for a cervical carcinoma. Br J Dermatol (1995) 0.77
Mechanisms of photoaging and chronological skin aging. Arch Dermatol (2002) 3.43
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09
A case of vitiligo induced by tattooing eyebrow. Int J Dermatol (2011) 1.54
AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J Biol Chem (2008) 1.44
Cytosolic dsDNA triggers apoptosis and pro-inflammatory cytokine production in normal human melanocytes. Exp Dermatol (2015) 1.42
Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J (2002) 1.29
EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration. Biochem J (2006) 1.24
SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med (2008) 1.24
DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter. J Biol Chem (2003) 1.21
Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal (2009) 1.14
MEK/ERK pathway mediates UVB-induced AQP1 downregulation and water permeability impairment in human retinal pigment epithelial cells. Int J Mol Med (2009) 1.13
Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol (2008) 1.09
All-trans retinoic acid attenuates ultraviolet radiation-induced down-regulation of aquaporin-3 and water permeability in human keratinocytes. J Cell Physiol (2008) 1.09
EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells. Cell Signal (2008) 1.06
alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res (2009) 1.04
EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther (2006) 1.03
UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway. Int J Mol Med (2006) 1.03
Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Int J Oncol (2006) 1.01
Rapamycin sensitive mTOR activation mediates nerve growth factor (NGF) induced cell migration and pro-survival effects against hydrogen peroxide in retinal pigment epithelial cells. Biochem Biophys Res Commun (2011) 1.00
ATP-sensitive potassium channel: a novel target for protection against UV-induced human skin cell damage. J Cell Physiol (2007) 0.98
Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int J Oncol (2005) 0.98
Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int J Oncol (2006) 0.97
Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer. Int J Oncol (2013) 0.97
Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways. Int J Mol Med (2008) 0.95
Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death. Int J Oncol (2005) 0.94
AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. Oncol Rep (2008) 0.94
Trans-Zeatin inhibits UVB-induced matrix metalloproteinase-1 expression via MAP kinase signaling in human skin fibroblasts. Int J Mol Med (2009) 0.92
Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncol Rep (2006) 0.92
Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol (2006) 0.92
siRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Oncol (2003) 0.92
p53-related apoptosis resistance and tumor suppression activity in UVB-induced premature senescent human skin fibroblasts. Int J Mol Med (2008) 0.91
Trans-Zeatin attenuates ultraviolet induced down-regulation of aquaporin-3 in cultured human skin keratinocytes. Int J Mol Med (2010) 0.90
Primary cutaneous extranodal NK/T-cell lymphoma, nasal type, in an adolescent. Eur J Dermatol (2009) 0.89
Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs. Cancer Lett (2008) 0.89
Nicotinamide attenuates aquaporin 3 overexpression induced by retinoic acid through inhibition of EGFR/ERK in cultured human skin keratinocytes. Int J Mol Med (2008) 0.89
Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway. EMBO Rep (2005) 0.88
Parameters of protection against ultraviolet radiation-induced skin cell damage. J Cell Physiol (2009) 0.88
Spontaneous regression of generalized eruptive histiocytosis: possible involvement of apoptosis? Int J Dermatol (2007) 0.88
Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS One (2012) 0.88
UVB radiation induces human lens epithelial cell migration via NADPH oxidase-mediated generation of reactive oxygen species and up-regulation of matrix metalloproteinases. Int J Mol Med (2009) 0.87
UV radiation down-regulates Dsg-2 via Rac/NADPH oxidase-mediated generation of ROS in human lens epithelial cells. Int J Mol Med (2006) 0.87
Extracellular matrix secreted by senescent fibroblasts induced by UVB promotes cell proliferation in HaCaT cells through PI3K/AKT and ERK signaling pathways. Int J Mol Med (2008) 0.87
Tumor necrosis factor-alpha (TNF-α)-mediated in vitro human retinal pigment epithelial (RPE) cell migration mainly requires Akt/mTOR complex 1 (mTORC1), but not mTOR complex 2 (mTORC2) signaling. Eur J Cell Biol (2012) 0.84
IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes. Int J Mol Med (2005) 0.83
UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. Int J Mol Med (2005) 0.82
Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo. Nanoscale (2015) 0.81
The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes. Mol Biosyst (2012) 0.81
N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells. Int J Oncol (2012) 0.81
Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells. Oncol Rep (2008) 0.81
Tumor necrosis factor-alpha-308G/A promoter polymorphism is associated with the susceptibility of polymyositis/dermatomyositis in a Chinese Han population. J Dermatol (2007) 0.81
Niacin protects against UVB radiation-induced apoptosis in cultured human skin keratinocytes. Int J Mol Med (2012) 0.80
The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes. Int J Mol Med (2010) 0.80
Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1. Ann N Y Acad Sci (2007) 0.79
Quercetin attenuates UV- and H(2)O(2)-induced decrease of collagen type I in cultured human lens epithelial cells. J Ocul Pharmacol Ther (2008) 0.78
Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report. Int J Dermatol (2009) 0.78
A case report of Dubowitz syndrome accompanied by congenital anal atresia. Int J Dermatol (2010) 0.77
Extracellular matrix activity and caveolae events contribute to cell surface receptor activation that leads to MAP kinase activation in response to UV irradiation in cultured human keratinocytes. Int J Mol Med (2005) 0.77
Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents. J Nanosci Nanotechnol (2016) 0.77
VIT1/FBXO11 knockdown induces morphological alterations and apoptosis in B10BR mouse melanocytes. Int J Mol Med (2009) 0.77
A novel lateral flow assay based on GoldMag nanoparticles and its clinical applications for genotyping of MTHFR C677T polymorphisms. Nanoscale (2016) 0.77
Tightly regulated distribution of family members of proteins is related to social property in the open body system (Review). Int J Mol Med (2006) 0.77
Protective effect of astragaloside IV against matrix metalloproteinase-1 expression in ultraviolet-irradiated human dermal fibroblasts. Arch Pharm Res (2011) 0.77
A mouse model of vitiligo induced by monobenzone. Exp Dermatol (2013) 0.76
Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency. PLoS One (2013) 0.76
Lead-induced cell signaling cascades in GT1-7 cells. Brain Res Bull (2003) 0.76
In vitro preparation and characterization of the human CD3 epsilon epsilon homodimer and CD3 epsilon gamma and CD3 epsilon delta heterodimers. Int J Mol Med (2009) 0.75
RNA-mediated gene regulation system: now and the future (Review). Int J Mol Med (2002) 0.75
Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death. Oncol Lett (2013) 0.75
Immunodetection of the MCHR1 antibody in vitiligo patient sera. Int J Mol Med (2011) 0.75
Activation of acetyl-coenzyme A carboxylase is involved in Taxol-induced ovarian cancer cell death. Oncol Lett (2011) 0.75
Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation. Cutis (2011) 0.75
In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation. Lasers Med Sci (2010) 0.75
Transplantation of autologous minigrafts for the treatment of stable vitiligo. J Dermatolog Treat (2011) 0.75
Transferable crosslinked chitosan membranes for human melanocyte culture. J Biomed Mater Res A (2011) 0.75
Melagenine modulates proliferation and differentiation of melanoblasts. Int J Mol Med (2008) 0.75
Correction: EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration. Biochem J (2017) 0.75
Follow-up study of vitiligo patients treated with autologous epidermal sheet transplants. J Dermatolog Treat (2013) 0.75
Transplantation of autologous minigrafts for the treatment of large-area segmental vitiligo. J Dermatolog Treat (2009) 0.75
The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial. J Drugs Dermatol (2012) 0.75
Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment. Biol Pharm Bull (2015) 0.75